top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Kixta 100mg Capsule

Kixta 100mg Capsule

Manufacturer/Marketed By : ZYDUS CADILA

$59.75 $29.95

Kixta 100mg Capsule contains the active ingredient Palbociclib, a targeted anticancer medicine belonging to the class of cyclin-dependent kinase inhibitors. It is prescribed for hormone receptor-positive, human epidermal growth factor...

PALBOCICLIB

Active Pharmaceutical Ingredient

Kixta 100mg Capsule

SKU KIXTA-100MG-CAPSULE
Original price

$59.75

Sale price

$29.95

Kixta 100mg Capsule contains the active ingredient Palbociclib, a targeted anticancer medicine belonging to the class of cyclin-dependent kinase inhibitors. It is prescribed for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. This therapy helps slow or stop the growth of cancer cells and is usually given in combination with other anticancer medicines. The Kixta 100mg Capsule dosage should be taken exactly as directed by your doctor. Swallow the capsule whole without crushing or chewing, following the correct Kixta 100mg Capsule administration technique. It can be taken with or without food, preferably at the same time each day. Proper Kixta 100mg Capsule storage involves keeping it in a cool, dry place away from moisture and sunlight. The key Kixta 100mg Capsule benefits include inhibiting cancer cell multiplication, controlling tumor progression, and improving overall treatment outcomes in patients with breast cancer. Patients can Buy Kixta 100mg Capsule online through trusted pharmacies. The Kixta 100mg Capsule price may vary depending on the supplier and pack size. For continued treatment, your doctor may recommend Kixta 100mg Capsule substitutes if required. This medicine is widely used as Kixta 100mg Capsule for breast cancer management under medical supervision.

Active Pharmaceutical Ingredient

PALBOCICLIB

Uses

• Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.

Benefits

Kixta 100mg Capsule is used to treat certain types of hormone receptor-positive, HER2-negative breast cancer. It works by slowing the growth and division of cancer cells, helping control disease progression and improve treatment outcomes.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Kixta 100mg Capsule side effects are

Most Common Side Effects

• Tiredness
• Hair loss
• Dry skin, rash
• Infections
• Low blood cell counts
• Decreased of appetite
• Nausea, vomiting
• Diarrhea
• Swelling of lips and mouth
• Changes in taste
• Nose bleed
• Dry eye, blurred vision, increased tearing

Common Side Effects

• Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising)
• Lung inflammation (chest pain, dry cough, or difficulty breathing)

How To Use

Take Kixta 100mg capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.

Safety Advice

• Breast Feeding: Taking a Kixta 100mg capsule while breastfeeding is not recommended as it is not known whether it passes into the breast milk.
• Alcohol: It is unknown whether it is safe to drink alcohol while taking Kixta 100mg capsule. Check with your doctor for advice.
• Liver: Inform your physician if you have any liver disorders before taking Kixta 100 mg capsule, as it should be used with caution in liver disorder patients.
• Lungs: It is not unknown whether Kixta 100mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Kixta 100mg capsule can cause tiredness. Avoid driving if you are unwell.
• Pregnancy: It is not recommended to take Kixta 100mg capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page